Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-04-001469
Filing Date
2004-10-22
Accepted
2004-10-22 16:14:53
Documents
2
Period of Report
2004-10-20

Document Format Files

Seq Description Document Type Size
1 ankcorn_ex.html 3  
1 ankcorn_ex.xml 3 2677
2 p_ankcorn.htm EX-24 5156
  Complete submission text file 0000950103-04-001469.txt   9755
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Issuer) CIK: 0001100682 (see all company filings)

EIN.: 061397316
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address INVERESK RESEARCH GROUP, INC. 87 SENNEVILLE ROAD SENNEVILLE, MONTREAL A8 H9X 3R3
Business Address
ANKCORN MICHAEL F (Reporting) CIK: 0001226479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15943 | Film No.: 041092068